Related references
Note: Only part of the references are listed.Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study
G. Houvenaeghel et al.
ESMO OPEN (2021)
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
G. Houvenaeghel et al.
ESMO OPEN (2021)
External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis
Gilles Houvenaeghel et al.
CANCERS (2020)
Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer
Y. Andersson et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy
Omar Picado et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2018)
Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
Gilles Houvenaeghel et al.
BMC CANCER (2018)
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study
A. de Nonneville et al.
EUROPEAN JOURNAL OF CANCER (2017)
Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial
T. Reimer et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Jana de Boniface et al.
BMC CANCER (2017)
SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes
Corrado Tinterri et al.
BREAST (2016)
Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes
G. Houvenaeghel et al.
EUROPEAN JOURNAL OF CANCER (2016)
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
L. M. van Roozendaal et al.
BMC CANCER (2015)
POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases
A. Goyal et al.
CLINICAL ONCOLOGY (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node
T. F. Tvedskov et al.
EJSO (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC
Gilles Houvenaeghel et al.
BULLETIN DU CANCER (2014)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2013)
Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models
Gilles Houvenaeghel et al.
BREAST (2012)
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag et al.
LANCET ONCOLOGY (2010)
A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis
G. Houvenaeghel et al.
EJSO (2009)
Micrometastases in sentinel lymph node in a multicentric study: Predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer
G Houvenaeghel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
